NEW YORK (360Dx) – Roche said this week that it has commenced a cash tender offer for all outstanding shares of common stock of Foundation Medicine at a price of $137 per share. The offer follows Roche's announcement last month that it plans to acquire all the remaining outstanding Foundation shares that it did not already own. Unless extended, the tender offer period will expire at midnight, US Eastern time, on July 30.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.